Latest News in the pharma Industry

CPhI Podcast: The distinction of drugs vs cosmetics from a regulatory perspective

23 Jul 2021

As more and more companies operating in the pharmaceutical space are moving into cosmetics, the temptation is to think that life will be much easier from a regulatory and compliance perspective.

Novartis shifts Leqvio manufacturing to Austrian facility

7 Jul 2021

Pharma firm tells FDA tech transfer to its own facility in Schaftenau, Austria is underway after regulator highlighted concerns about third party CDMO site in Italy

CPhI Webinar: How is M&A Shifting the Pharma Manufacturing Landscape?

6 Jul 2021

Watch this CPhI Webinar sponsored by PharmaVentures, in which a broad panel of experts across the pharmaceutical manufacturing space discussed how M&A activity is being shaped by this ever evolving and complex sector

Cannabinoids: The Next Frontier for Cosmeceuticals?

18 Jun 2021

The market for CBD is growing and it is not just the pharmaceutical industry that is exploring its potential. Martin Oxley, MD at buzzback UK explains how consumer interest in plant-based ingredients and natural products present huge opportunities for ...

Pandemic creates extra demand for CDMO services but investment decisions remain key to success

15 Jun 2021

While the COVID-19 pandemic has created even greater demand for partnerships, CDMOs need to be aware that the needle has shifted, creating both opportunities and challenges and changing how the services industry does business

Robust sales growth at Indian pharma companies expected in current FY on pandemic recovery, says Fitch

14 Jun 2021

Drug categories impacted by travel restrictions expected to see higher sales levels in FY22

Continuous manufacturing: CDMOs have a huge role to play in helping deliver wider adoption

11 Jun 2021

During CPhI Discover (17th-28th May, 2021) – global pharma’s largest ever virtual gathering – we spoke with Doug Hausner, Senior Manager Continuous Manufacturing at Thermo Fisher Scientific. He presented his views on how continuous ma...

EmpowerPharm certified to manufacture CBD products to prescription drug standards in Canadian first

8 Jun 2021

New $30 million manufacturing facility in Burlington, Ontario, will allow company to manage R&D in-house and scale production without reliance on third-party manufacturers

Pandemic inevitably slows pharma M&A activity but appetite for deals remains

4 Jun 2021

The initial outbreak of the COVID-19 pandemic delayed merger and acquisitions in the pharma sector, but evidence points to an uptick in activity because the rationale for sealing deals hasn’t changed

The Top Ten CPhI Discover Company Showcases

3 Jun 2021

CPhI Discover (May 17-28) gave Pharma companies, suppliers and service providers the opportunity to keep potential buyers and partners abreast of the latest news, product information and market trends in the form of free-to-access, downloadable content...

Lonza to install new production line at Geleen to increase Moderna COVID-19 vaccine output by 300 million doses per year

2 Jun 2021

Drug substance production line expected to be operational by end of 2021 as part of CDMO’s expanded collaboration with biotech

Finding the right experts and collaborating at speed essential to COVID-19 vaccine rollout, says CPhI panel

21 May 2021

CPhI Discover webinar examines the progress made so far in terms of vaccine distribution to the global population as well as anticipating future challenges